Clinical and Life Sciences · 29 September 2026 to 29 September 2026 · 1 headlines · MedPage Today
Thyroid Drug Recall Most Serious; GLP-1s and Vitamin Deficiency; New T1D Guidelines
A thyroid drug recall has been classified at the most serious level, GLP-1 medications have been linked to vitamin deficiency, and new guidelines for type 1 diabetes have been issued.
As it ran
29 September 2026
More from US healthcare
- Trump Administration Suppressed USPSTF Recommendations 29 September 2026
- The Illegal Drug Marketplace in Your Patients’ Pockets 29 September 2026
- Vaccine and drug policy in the midterm elections 29 September 2026
- FDA Approves First Treatment for Rare Thyroid Hormone Disorder 29 September 2026
- STAT Plus: Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event 29 September 2026
- STAT Plus: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property 29 September 2026
- STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal 29 September 2026
- STAT Plus: The last ‘breakthrough’ devices to get special treatment from Medicare 29 September 2026